scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1875-5364(15)30075-3 |
P698 | PubMed publication ID | 26481375 |
P2093 | author name string | Shao-Jun Chen | |
P2860 | cites work | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation | Q24616946 | ||
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review | Q27008867 | ||
Network biology: understanding the cell's functional organization | Q27861027 | ||
Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
STITCH: interaction networks of chemicals and proteins | Q28465606 | ||
Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes | Q44803775 | ||
Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge | Q44842680 | ||
Tanshinone II-A: new perspectives for old remedies | Q45746307 | ||
Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal‐regulated protein kinase pathways in rats challenged with seawater exposure | Q45841986 | ||
c-Src-dependent transactivation of PDGFR contributes to TNF-α-induced MMP-9 expression and functional impairment in osteoblasts | Q46399877 | ||
An architecture for biological information extraction and representation | Q48507596 | ||
Protein-protein interaction network analysis and gene set enrichment analysis in epilepsy patients with brain cancer | Q48869986 | ||
Computing topological parameters of biological networks | Q51900389 | ||
Network pharmacology | Q57932497 | ||
Target network analysis of adiponectin, a multifaceted adipokine | Q85563401 | ||
Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology | Q28487019 | ||
Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network | Q28533728 | ||
Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach | Q28535430 | ||
A travel guide to Cytoscape plugins | Q29788355 | ||
STITCH 3: zooming in on protein-chemical interactions | Q30002340 | ||
Systematic identification of proteins that elicit drug side effects | Q30002377 | ||
Topological analysis and interactive visualization of biological networks and protein structures | Q30414346 | ||
Drug discovery in the age of systems biology: the rise of computational approaches for data integration. | Q30485238 | ||
Sodium tanshinone IIA sulfonate protects rat myocardium against ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim pathway | Q33551875 | ||
SRC: A Century of Science Brought to the Clinic | Q34041298 | ||
Predicting new molecular targets for rhein using network pharmacology | Q34203691 | ||
Neuron Regeneration and Proliferation Effects of Danshen and Tanshinone IIA. | Q34382511 | ||
Visual data mining of biological networks: one size does not fit all. | Q34557957 | ||
Network pharmacology-based prediction of the multi-target capabilities of the compounds in Taohong Siwu decoction, and their application in osteoarthritis | Q34917499 | ||
Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models. | Q34927731 | ||
Retracted: TNF-α Induces Cytosolic Phospholipase A2 Expression in Human Lung Epithelial Cells via JNK1/2- and p38 MAPK-Dependent AP-1 Activation | Q34998514 | ||
Detecting overlapping protein complexes in protein-protein interaction networks | Q36528169 | ||
Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. | Q36637897 | ||
Hubba: hub objects analyzer--a framework of interactome hubs identification for network biology | Q36749291 | ||
Network pharmacology: a new approach for chinese herbal medicine research | Q36900056 | ||
Cytochromes p450: roles in diseases | Q36928922 | ||
Neuroprotective effects of tanshinone I from Danshen extract in a mouse model of hypoxia-ischemia | Q37264903 | ||
AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise? | Q37671290 | ||
Targeting inflammation by modulating the Jun/AP-1 pathway | Q37845556 | ||
Cardiovascular actions and therapeutic potential of tanshinone IIA | Q37903088 | ||
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. | Q37996420 | ||
Network cluster analysis of protein-protein interaction network identified biomarker for early onset colorectal cancer | Q38483765 | ||
Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo. | Q39094910 | ||
Exploring and challenging the network of angiogenesis. | Q39120436 | ||
Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells | Q39132731 | ||
Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL‐6/STAT3/NF‐kB signaling pathways | Q39171958 | ||
Tanshinone IIA protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway | Q39399964 | ||
Significant overlapping modules and biological processes between stroke and coronary heart disease | Q42634622 | ||
Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro | Q42967378 | ||
Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway | Q43110452 | ||
Protective effect of Tanshinone IIA against infarct size and increased HMGB1, NFκB, GFAP and apoptosis consequent to transient middle cerebral artery occlusion | Q44021066 | ||
P433 | issue | 10 | |
P921 | main subject | data mining | Q172491 |
P304 | page(s) | 751-759 | |
P577 | publication date | 2015-10-01 | |
P1476 | title | Drug-target networks for Tanshinone IIA identified by data mining | |
P478 | volume | 13 |
Q91575139 | Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway |
Q58101390 | The anticancer mechanism investigation of Tanshinone II by pharmacological clustering in protein network |
Search more.